TREATMENT UPTAKE AND REAL WORLD EFFECTIVENESS OF SOFOSBUVIR/LEDIPASVIR AND PARITAPREVIR/RITONAVIR/OMBITASVIR/DASABUVIR AMONG HCV-INFECTED PERSONS WITH CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Alkadi, Mohamad
Ren, Yanjie
Puenpatom, Amy
Kumar, Ritesh
Arduino, Jean Marie
Abou-Samra, Abdul-Badi
Butt, Adeel
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33707-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1536
引用
收藏
页码：S1100 / S1101
页数：2
相关论文
共 50 条
  • [1] Treatment uptake and real world effectiveness of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir/dasabuvir among HCV-infected persons with chronic kidney disease
    Alkadi, M. M.
    Ren, Y.
    Puenpatom, A.
    Kumar, R.
    Arduino, J. M.
    Abou-Samra, A-B
    Butt, A. A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S724 - S725
  • [2] Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir plus dasabuvir in patients with chronic kidney disease: an ERCHIVES study
    Butt, A. A.
    Ren, Y.
    Puenpatom, A.
    Arduino, J. M.
    Kumar, R.
    Abou-Samra, A-B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 35 - 43
  • [3] POPULATION PHARMACOKINETICS OF OMBITASVIR, PARITAPREVIR, RITONAVIR AND DASABUVIR IN HCV-INFECTED SUBJECTS WITH CHRONIC KIDNEY DISEASE STAGE 4 OR STAGE 5
    Shuster, D. L.
    Eckert, D.
    Mensing, S.
    Dutta, S.
    Menon, R.
    Zha, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S88 - S88
  • [4] SAFETY & EFFICACY OF COMBINATION THERAPY WITH OMBITASVIR, PARITAPREVIR & RITONAVIR PLUS DASABUVIR IN HCV-INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS
    Lazarou, Dimitrios
    Xynotroulas, Ioannis
    Provatopoulou, Simella
    Vogiatzi, Apostolia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [5] Ombitasvir/paritaprevir/ritonavir plus dasabuvir combination in the treatment of chronic HCV infection
    Lucejko, Mariusz
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (08) : 1153 - 1164
  • [6] COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR PATIENTS WITH CHRONIC HCV IN THE NETHERLANDS
    Gaultney, J.
    de Knegt, R. J.
    Fassler, P.
    Visser, S.
    Johnson, S.
    VALUE IN HEALTH, 2015, 18 (07) : A588 - A588
  • [7] Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
    Degertekin, Bulent
    Demir, Mehmet
    Akarca, Ulus S.
    Kani, Haluk Tarik
    Ucbilek, Enver
    Yildirim, Emre
    Guzelbulut, Fatih
    Balkan, Ayhan
    Vatansever, Sezgin
    Danis, Nilay
    Demircan, Melek
    Soylu, Aliye
    Yaras, Serkan
    Kartal, Aysun
    Kefeli, Ayse
    Gunduz, Feyza
    Yalcin, Kendal
    Erarslan, Elife
    Aladag, Murat
    Harputluoglu, Murat
    Ozakyol, Aysegul
    Temel, Tuncer
    Akarsu, Mesut
    Sumer, Hale
    Akin, Mete
    Albayrak, Bulent
    Sen, Ilker
    Alkim, Huseyin
    Uyanikoglu, Ahmet
    Irak, Kader
    Oztaskin, Sinem
    Ugurlu, Cagri Burak
    Gunes, Sevkican
    Gurel, Selim
    Nuriyev, Kenan
    Inci, Ismail
    Kacar, Sabite
    Dincer, Dinc
    Doganay, Levent
    Gokturk, Huseyin Savas
    Mert, Ali
    Cosar, Arif Mansur
    Dursun, Hakan
    Atalay, Roni
    Akbulut, Sabiye
    Balkan, Yasemin
    Koklu, Hayrettin
    Simsek, Halis
    Ozdogan, Osman
    Coban, Mehmet
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (12): : 883 - 893
  • [8] Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System
    Ioannou, George N.
    Beste, Lauren A.
    Chang, Michael F.
    Green, Pamela K.
    Lowy, Elliott
    Tsui, Judith I.
    Su, Feng
    Berry, Kristin
    GASTROENTEROLOGY, 2016, 151 (03) : 457 - +
  • [9] Effect of Chronic Kidney Disease on the Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir in Subjects with HCV Genotype 1 Infection
    Shuster, Diana L.
    Menon, Rajeev
    Cohen, Daniel E.
    Khatri, Amit
    HEPATOLOGY, 2015, 62 : 744A - 745A
  • [10] All Oral Antiviral Treatment with Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir in Chronic HCV Infection - Real Life Experience
    Iliescu, Laura
    Mercan-Stanciu, Adriana
    Toma, Letitia
    Dodot, Mihai
    Isac, Teodora
    Grumeza, Mihaela
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 138 - 143
12345